---
title: 'Senior Product Manager at PhaseV'
canonical: 'https://feeny.ai/job/senior-product-manager-phasev-dereck-ha-shalom-st-4-7xtygskj080m'
type: 'job'
last_seen: '2026-09-11'
---

# Senior Product Manager at PhaseV

- **Company:** PhaseV
- **Location:** Dereck Ha'Shalom St 4
- **Posted:** 2025-11-20
- **Last confirmed live:** 2026-09-11
- **Apply:** https://job-boards.greenhouse.io/phasev/jobs/4064536009

## Job description

The Position

We're seeking a talented, experienced Product Manager to join our Tel Aviv team. In this role, you'll tackle the thrilling challenge of building an intuitive, efficient platform that redefines how clinical trials are designed and conducted, leveraging AI and innovation to transform drug development. You'll collaborate closely with our engineering, data science, algorithm research, and clinical teams to create and refine a state‑of‑the‑art trials platform. This is a rare opportunity to make a tangible impact on how new therapies reach patients and to revolutionize healthcare delivery.

## Key Responsibilities

- Bridge end‑user needs and AI‑powered capabilities to design and deliver transformative products
- Play a critical role in defining the product vision and roadmap
- Work closely with engineering and algorithm developers to fulfill product goals
- Turn strategic goals into focused, compelling product plans
- Create structure, focus, and momentum within fast-moving environments
- Actively engage with customers and internal stakeholders throughout the product development lifecycle

Required Qualifications

- 4+ years of product management experience (Preferably on a B2B product)
- Proactive learner who rapidly builds deep domain expertise
- Thrive in fast‑paced settings, seamlessly switching contexts across multiple initiatives
- Ownership mindset that drives accountability and empowers cross‑functional teams
- Hands-on experience collaborating with engineering and data-science teams on product development
- Familiarity with AI tools, workflows, and opportunities
- Comfortable with statistics, able to engage meaningfully with data‑science counterparts (advantage)

## About Us

PhaseV (HQ in Boston, R&D in Tel Aviv) is a fast-moving startup redefining clinical trial design with a cloud-native, AI-first platform. Founded in 2023, we combine causal machine learning, adaptive trial design, and real-world data to deliver smarter, faster, and more efficient drug development.

Backed by a $50 million Series A, we’re enabling sponsors, biotechs, and CROs to uncover hidden insights, optimize trial scenarios in real time, and accelerate the path from molecule to medicine.

At PhaseV, every innovation has one destination: speeding critical treatments from lab to patient.

## About PhaseV

## Company Overview
- **One-liner**: PhaseV provides an enterprise AI/ML platform that optimizes every stage of clinical drug development, helping biopharma sponsors and CROs design smarter, faster, and more cost-effective trials.
- **Entity Type**: Private (Series A)
- **Headquarters**: Cambridge, Massachusetts, United States (with offices in Tel Aviv, Israel; London, UK; and the Netherlands)
- **Founded**: 2023
- **Founders**: Raviv Pryluk, PhD (CEO, Co-Founder); Elad Berkman, MSc (CTO, Co-Founder); Dan Goldstaub, PhD (Scientific Co-Founder)

## Core Business
- **Primary Industry**: Biotechnology Research / Healthcare AI
- **Target Customers**: Biopharma sponsors and Contract Research Organizations (CROs) – B2B, Enterprise
- **Mission**: To revolutionize clinical development by using causal machine learning and AI to accelerate decisions, de-risk trials, and bring life-saving treatments to patients faster and more efficiently.

## Products & Services
- **[Trial Optimizer](https://www.phasevtrials.com/)**: AI-powered tool that designs adaptive and Bayesian clinical trials, runs millions of simulations within minutes, and enables real-time data-driven decisions to reduce costs by up to 50%, lower enrollment by 40%, shorten timelines by 40%, and boost probability of success by 30%+.
- **[ClinOps Optimizer](https://www.phasevtrials.com/)**: Causal-ML driven site selection and real-time dashboards for trial and site performance analytics.
- **[Lifecycle Management / Portfolio Optimizer](https://www.phasevtrials.com/)**: Combines causal evidence, development complexity, and market value to inform indication selection, asset viability, and portfolio decisions.
- **[Response Optimizer](https://www.phasevtrials.com/)**: Identifies optimal subgroups and biomarkers by detecting heterogeneity in complex biological signals and multi-variable clinical data.
- **Early-Derived Endpoint Identification**: Predicts and validates early-derived endpoints to accelerate decision-making, with proven case studies in neurology and immunology.

## Market Standing
- **Valuation/Market Cap**: Not publicly available
- **Key Metric**: Total Funding of **$65M** (Seed $15M led by EXOR N.V. and Viola Ventures in Oct 2023; Series A $50M led by Insight Partners and Accel in June 2025)
- **Annual Revenue**: Estimated **$32M** (per LinkedIn)
- **Notable Investors/Partners**: Insight Partners, Accel, EXOR N.V., Viola Ventures
- **Growth Signals**:
  - Headcount grew **90.6% year-over-year** to 52 employees (as of mid-2026)
  - **45+** biopharma and CRO customers
  - **10M+** patient-level records in data lake
  - **50+** disease predictive models
  - **10+** scientific publications
  - **6,598** LinkedIn followers (+114.7% yearly)

## Competitive Advantages
- **Causal ML & GenAI Core**: Unlike traditional AI, PhaseV uses causal inference to understand why treatments work, enabling more accurate predictions and adaptive trial designs.
- **Expansive Data Lake**: 10M+ patient-level records combined with real-world data (RWD) to train models and validate endpoints.
- **Multidisciplinary Team**: Combines veterans in machine learning, statistics, software engineering with clinical and pharma experts who have deep practical experience in optimization.
- **Proven Results**: Real-world collaborations showing 30%+ higher probability of success, 40% lower costs, 40% shorter timelines, and 40% reduced enrollment.

## Strategic Focus
- **Platform Adoption**: Scaling the enterprise platform across more biopharma sponsors and CROs globally.
- **Partnerships**: Deepening relationships with strategic accounts and expanding alliance management.
- **Indication Expansion**: Applying causal ML across various therapeutic areas beyond neurology and immunology.
- **Talent Growth**: Rapidly hiring across data science, engineering, business development, and clinical roles in both Boston and Tel Aviv.

## Why Work Here
- **Meaningful Impact**: Directly contribute to bringing life-saving treatments to patients faster by optimizing clinical trials.
- **Cutting-Edge Technology**: Work with advanced AI/ML, causal inference, and GenAI tools to solve complex healthcare challenges.
- **Collaborative Culture**: Join a diverse, multidisciplinary team of experts from healthcare, technology, and life sciences.
- **Growth Trajectory**: 90%+ headcount growth, recent $50M Series A, and strong commercial momentum offer significant career advancement opportunities.
- **Locations**: Hybrid/office presence in Boston, MA and Tel Aviv, Israel with some remote flexibility. Offices also in London and Netherlands.
- **Perks**: Not explicitly listed, but the careers page emphasizes meaningful impact, collaborative culture, and cutting-edge technology as key draws. [phasevtrials.com/careers](https://www.phasevtrials.com/careers)

## Sources
1. [phasevtrials.com](https://www.phasevtrials.com/) – Product descriptions, company overview, results
2. [phasevtrials.com/about](https://www.phasevtrials.com/about) – Founders, mission, team overview
3. [phasevtrials.com/careers](https://www.phasevtrials.com/careers) – Careers page, why join, open roles
4. [linkedin.com/company/phasevtrials](https://www.linkedin.com/company/phasevtrials) – Employee count, revenue, funding, headcount growth, locations, departments
5. [cbinsights.com/company/phasev](https://www.cbinsights.com/company/phasev) – Founded year, stage, description, former name

## Other roles at PhaseV

- [Legal & Business Operations Director (US)](https://feeny.ai/job/legal-business-operations-director-us-phasev-one-broadway-11th-floor-cambridge-arxvny4yeaer) — One Broadway 11th Floor Cambridge MA 02142, United States
- [Strategy and Market Intelligence Intern](https://feeny.ai/job/strategy-and-market-intelligence-intern-phasev-one-broadway-11th-floor-qpc63052g60b) — One Broadway 11th Floor Cambridge MA 02142, United States
- [Medical Director](https://feeny.ai/job/medical-director-phasev-one-broadway-11th-floor-cambridge-ma-02142-g19j9srx1h92) — One Broadway 11th Floor Cambridge MA 02142, United States
- [Senior Data Scientist](https://feeny.ai/job/senior-data-scientist-phasev-one-broadway-11th-floor-cambridge-ma-02142-09jrk30xfb17) — One Broadway 11th Floor Cambridge MA 02142, United States
- [QA Engineer](https://feeny.ai/job/qa-engineer-phasev-dereck-ha-shalom-st-4-2f11e71xht8k) — Dereck Ha'Shalom St 4
- [Director/ Sr. Director of Alliance Management, Strategic Accounts](https://feeny.ai/job/director-sr-director-of-alliance-management-strategic-accounts-phasev-one-52fpg526p7qj) — One Broadway 11th Floor Cambridge MA 02142, United States
- [Senior Director of Business Development](https://feeny.ai/job/senior-director-of-business-development-phasev-one-broadway-11th-floor-0n6dkvtfw7km) — One Broadway 11th Floor Cambridge MA 02142, United States
- [Associate Director / Director of Business Development](https://feeny.ai/job/associate-director-director-of-business-development-phasev-one-broadway-11th-8t88wxg77by3) — One Broadway 11th Floor Cambridge MA 02142, United States
- [Senior Software Engineer](https://feeny.ai/job/senior-software-engineer-phasev-one-broadway-11th-floor-cambridge-ma-02142-d51pkky1zmfr) — One Broadway 11th Floor Cambridge MA 02142, United States
- [Senior Backend Developer](https://feeny.ai/job/senior-backend-developer-phasev-dereck-ha-shalom-st-4-dwk9wjpaa0sn) — Dereck Ha'Shalom St 4